Fluoroquinolones in the management of tuberculous meningitis: Systematic review and meta-analysis
Abstract
OBJECTIVES: Tuberculous meningitis carries a high rate of mortality and morbidity despite of an adequate treatment. Newer agents are being searched to improve outcome of these patients. Fluoroquinolones might be useful in the management of tuberculous meningitis in view of good cerebrospinal fluid penetration and good in-vitro activity against the mycobacterium. This review summarizes the effects of fluoroquinolone in first line regimens in tuberculous meningitis.
METHODS: A systematic search of literature was performed using PubMed, Cochrane Central Register of Controlled Trials (CENTRAL) and LILACS for articles published till march 2017. We also searched meta-register of controlled trials and bibliography of relevant studies. Randomized controlled trials (RCTs) where a fluoroquinolone was administered in addition or substitution of standard antituberculosis drugs formed the basis of selection criteria. Data was extracted on a pre-specified format. Risk ratio (RR) for dichotomous data was calculated and fixed effect model was used to combined the data if no heterogeneity was found. Death was taken as the primary outcome measure.
RESULTS: Five trials including 1115 patients of tuberclous meningitis were included. Addition of a fluoroquinolone to a standard regimen was not found to significantly reduce mortality [RR = 0.68 (0.30-1.52)] (low-quality evidence). Addition of a fluoroquinolone to an intensified regimen (containing high dose rifampicin) was not found to…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 1,115 participants or records.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.